SCHEMBL25417641

SCHEMBL25417641

CC(C)(C)OC(=O)N1C(C=O)CC(C=O)N1C(=O)OC(C)(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.47
CHRM2 P08172 1/20 0.43
CHRM1 P11229 1/20 0.43
CHRM3 P20309 1/20 0.43
USP2 O75604 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CTSK P43235 1/20 0.38
DDB1 Q16531 1/20 0.37
CRBN Q96SW2 1/20 0.37
HPGD P15428 1/20 0.36
FAAH O00519 1/20 0.36
EPHX2 P34913 1/20 0.36
RECQL P46063 1/20 0.34
EPHX1 P07099 1/20 0.34
PREP P48147 1/20 0.34
HSD11B1 P28845 1/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2277430 0.77 NR1H2 (0.44) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL30700601 0.76 NR1H2 (0.48) NR1H2CHRM2CHRM1CHRM3SMN1; SMN2
SCHEMBL16584672 0.76 NR1H2 (0.48) NR1H2CHRM2CHRM1CHRM3SMN1; SMN2
SCHEMBL24909283 0.76 NR1H2 (0.48) NR1H2CHRM2CHRM1CHRM3SMN1; SMN2
SCHEMBL609610 0.76 NR1H2 (0.48) NR1H2CHRM2CHRM1CHRM3SMN1; SMN2
SCHEMBL609346 0.76 NR1H2 (0.48) NR1H2CHRM2CHRM1CHRM3SMN1; SMN2
SCHEMBL15996597 0.75 CHRM2 (0.46) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL25510610 0.75 CHRM2 (0.46) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL19296178 0.75 CHRM2 (0.46) NR1H2CHRM2CHRM1CHRM3USP2
SCHEMBL14899628 0.75 CHRM2 (0.46) NR1H2CHRM2CHRM1CHRM3USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4713320-A2 BCAT2 INHIBITORS Agios Pharmaceuticals, Inc. (US) 2026-03-25 EP disclosed
WO-2024238820-A2 BCAT2 INHIBITORS AGIOS PHARMACEUTICALS, INC. (US) 2024-11-21 WO disclosed
EP-4430036-A2 BCAT2 INHIBITORS Agios Pharmaceuticals, Inc. (US) 2024-09-18 EP disclosed
WO-2023086539-A2 BCAT2 INHIBITORS AGIOS PHARMACEUTICALS, INC. (US) 2023-05-19 WO disclosed